Revolutionizing Lyme disease vaccination: a systematic review and meta-analysis of promising candidates
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1554360 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Sadia Tamanna und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, College of Medicine, Chosun University, Gwangju, Republic of Korea. Hauptthemen laut MEDLINE: Lyme Disease, Lyme Disease Vaccines, Borrelia burgdorferi, Vaccination. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The most prevalent vector-borne diseases in North America and Europe is still Lyme disease, which is caused by the bacterium Borrelia burgdorferi . As incidence rates rise, this poses a serious threat to public health. Since there is presently no vaccine for Lyme disease that is suitable for human use after the LYMErix vaccine was withdrawn in 2002 due to safety issues and insufficient adoption, there is an urgent need for an effective vaccination to protect at-risk populations. Numerous intriguing vaccine candidates have been developed as a result of advances in molecular biology and immunology; nevertheless, it is still unclear which candidate provides the best balance of durability, safety, and efficacy. The purpose of this meta-analysis and systematic review is to assess the safety and effectiveness of many Lyme disease vaccine candidates that are presently undergoing clinical trials. According to PRISMA guideline, the systematic review was performed, and the meta-analysis was performed using random-effect model. This study evaluates the efficacy of multiple Lyme disease vaccine candidates and identifies recombinant OspA-based formulations as the most promising by combining data from observational studies and randomized controlled trials. With an emphasis on OspA-based and multivalent vaccinations, we present comparative evaluations of immune responses, side effects, and long-term protection across vaccine platforms. This research is to help steer public health policy and vaccine development activities in the direction of a successful Lyme disease vaccine and emphasizes how certain vaccine candidates may lessen the impact of Lyme disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, College of Medicine, Chosun University, Gwangju, Republic of Korea.
Zitieren
APA
Tamanna, S., & Kim, D. M. (2025). Revolutionizing Lyme disease vaccination: a systematic review and meta-analysis of promising candidates. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1554360
Vancouver
Tamanna S, Kim DM. Revolutionizing Lyme disease vaccination: a systematic review and meta-analysis of promising candidates. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1554360
BibTeX
@article{Tamanna2025,
author = {Tamanna, Sadia and Kim, Dong-Min},
title = {Revolutionizing Lyme disease vaccination: a systematic review and meta-analysis of promising candidates},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1554360}
}
EUVIMED